Drawing for CANTRIXIL

USPTO serial 79243188

CANTRIXIL

Reviewed by CopyMark Law Group

Reg. 5760023Status 709
Filing date
Status date
Registration date
May 28, 2019
Examiner
WRIGHT, MARCO JABBAR
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CANTRIXIL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for treating cancer; anti-cancer pharmaceutical preparations; pharmaceutical preparations for the diagnosis and treatment of cancer; medicines for treating cancer for human use; pharmaceutical products for treating cancer; pharmaceutical compounds for treating cancer; chemical preparations for pharmaceutical purposes, namely, for treating cancer; chemical preparations for treating cancer; diagnostic preparations for medical purposesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 12, 2026INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Dec 12, 2025C71TCANCELLED SECTION 71—
Jul 3, 2025CHLDCHANGE OF OWNER RECEIVED FROM IB—
Jun 19, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 5, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 17, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 16, 2019FIMPFINAL DISPOSITION PROCESSED—
Aug 28, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 28, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 12, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 8, 2019GPNXNOTIFICATION PROCESSED BY IB—
Feb 20, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 20, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 20, 2019NPUBNOTICE OF PUBLICATION—
Feb 1, 2019ALIEASSIGNED TO LIE—
Jan 16, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 15, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 14, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 14, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 11, 2019RFNPREFUSAL PROCESSED BY IB—
Dec 27, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Dec 27, 2018RFRRREFUSAL PROCESSED BY MPU—
Dec 16, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 15, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 13, 2018DOCKASSIGNED TO EXAMINER—
Oct 23, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 19, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 18, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance